1. K Hruska (2014). Pavlik: Crohn's disease and related inflammatory diseases: from a single hypothesis to one "superhypothesis. Veterinarni Medicina, 59, 583-630.
2. G Monif (2015). The Hruska postulate of Crohn's disease. Med Hypoth, 85, 878-881.
3. G Monif (2016). The Mycobacterium avium subspecies paratuberculosis dilemma. Biol. Med, 8, 279.
4. John Sever,J Brody,G Schiff (1965). Rubella Epidemic on St. Paul Island in the Pribilofs, 1963. JAMA, 191(8), 624.
5. C Buergelt,J Williams,G Monif (2004). Spontaneous clinical remission of John's disease in a Holstein cow. Int. J. Applied Res. Vet. Med, 2, 126-128.
6. G Monif,J Williams (2015). Relationship of intestinal eosinophilia and the acid-fast bacilli in Johne's disease. Intern/ J. Appl. Med, 13, 147-149.
7. Gilles Monif (2016). Translation of Hypothesis to Therapy in Crohnʼs Disease. Inflammatory Bowel Diseases, 22(2), E8-E9.
8. Lothar Rink,P Gabriel (2000). Zinc and the immune system. Proceedings of the Nutrition Society, 59(4), 541-552.
9. Saul Powell (2000). The Antioxidant Properties of Zinc. The Journal of Nutrition, 130(5), 1447S-1454S.
10. L Gaetke,C Mcclain,R Talwalkar,S Shedlosky (1997). Effects of endotoxin on zinc metabolism in human volunteers. AM. J. Physiol, 272, 952-956.
11. L Valberg,P Flanagan,A Kertesz,D Bondy (1986). Zinc absorption in inflammatory bowel disease. Dig. Dis. Sci, 31, 724-731.
12. A Prasad,F Beck,S Grabowski,J Kaplin,R Mathog (1977). Zinc deficiency: changes in cytokine production and T-cell subpopulations in patients with head and neck cancer and non-cancer patients. Proc. Assoc. Am. Physicians, 109, 68-77.
13. A Prasad (2000). Effects of zinc deficiency on Th1 and Th2 cytokine shifts. J. Infect. Dis, 182, 62-68.
14. Eva Wintergerst,Silvia Maggini,Dietrich Hornig (2007). Contribution of Selected Vitamins and Trace Elements to Immune Function. Annals of Nutrition and Metabolism, 51(4), 301-323.
15. Craig Mc Clain,Carol Soutor,Leslie Zieve (1980). Zinc deficiency: A complication of Crohn's disease. Gastroenterology, 78(2), 272-279.
16. John Arthur,Roderick Mckenzie,Geoffrey Beckett (2003). Selenium in the Immune System. The Journal of Nutrition, 133(5), 1457S-1459S.
17. J Hogen,W Weiss,K Smith (1993). Role of vitamins and selenium in host defense against mastitis. J. Dairy Sci, 76, 2795-2803.
18. J Wichtel (1998). A review of selenium deficiency in grazing ruminants Part 1: New roles for selenium in ruminant metabolism. New Zealand Veterinary Journal, 46(2), 47-52.
19. D Walsh,D Kennedy,S Kennedy (1993). Antioxidant enzyme activity in the muscles of calves depleted of vitamin E or selenium or both. Br. J. Nutr, 70, 621-630.
20. E Andrews,W Hartley,A Grant (1968). Selenium-responsive diseases of animals in New Zealand. New Zealand Veterinary Journal, 16(1-2), 3-17.
21. François Girodon,P Galan,A Monget (1999). Impact of Trace Elements and Vitamin Supplementation on Immunity and Infections in Institutionalized Elderly Patients. Archives of Internal Medicine, 159(7), 748.
22. C Daniel (2008). immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change in T helper (Th) 1/17 to a Th2and regulatory T cell profile. J. Pharmacol. Exp. Ther, 324, 2-33.
23. Jun Tang,Ru Zhou,Dror Luger,Wei Zhu,Phyllis Silver,Rafael Grajewski,Shao-Bo Su,Chi-Chao Chan,Luciano Adorini,Rachel Caspi (2009). Calcitriol Suppresses Antiretinal Autoimmunity through Inhibitory Effects on the Th17 Effector Response. The Journal of Immunology, 182(8), 4624-4632.
24. Cristiana Almerighi,Anna Sinistro,Antonella Cavazza,Chiara Ciaprini,Giovanni Rocchi,Alberto Bergamini (2009). 1α,25-Dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in Human Monocytes. Cytokine, 45(3), 190-197.
25. E Wintergerst,S Maggini,D Horning (2006). Immuneenhancing role of vitamin C and zinc and effect on clinical conditions Ann. Nutri. Metab, 50, 85-94.
26. A Webb,E Villamor (2007). Effects of antioxidant and non-antioxidant vitamins on the Immune system. Nutr. Rev, 65, 181-217.
27. S Banc (1982). Immunosti-mulation by vitamin C. Int. J. Vitam. Nutr. Res. Suppl, 23, 49-52.
28. Akira Murata,Reiko Oyadomari,Tadashi Ohashi,Kazuko Kitagawa (1975). Virus-inactivating effect of ascorbic acid. IV. Mechanism of inactivation of bacteriophage .DELTA..DELTA. containing single-stranded DNA by ascorbic acid. Journal of Nutritional Science and Vitaminology, 21(4), 261-269.
29. A Furuya,M Uozaki,H Yamasaki (2008). Antiviral effects of ascorbic and dehydroascorbic acid Int. J. Mol. Med, 22, 541-545.
30. T Levy (2002). Curing the Incurable: Vitamin C. Infectious Diseases, and Toxins
31. S Hickey,A Saul (2008). Vitamin C: The Real Story, the Remarkable and Controversial Healing Factor. Vitamin C: The Real Story, the Remarkable and Controversial Healing Factor
32. J Warren,H Rees,T Cox (1886). Remission of Crohn's Disease with Tuberculosis Chemotherapy. New England Journal of Medicine, 314(3), 182-182.
33. T Borody,S Bilkey,A Wettstein,S Leis,G Pang,S Tye (2007). Anti-mycobacterial therapy in Crohn's disease heals mucosa with longitudinal scars. Digestive and Liver Disease, 39(5), 438-444.
34. William Chamberlin,George Ghobrial,Mounir Chehtane,Saleh Naser (2007). Successful Treatment of a Crohn's Disease Patient Infected With Bacteremic Mycobacterium paratuberculosis. The American Journal of Gastroenterology, 102(3), 689-691.
35. I Shafran,P Burgeunder (2008). Rifaximin for the treatment of newly diagnosed Crohn's disease: a case series. Am. J. Gastroenterol, 103, 2158-2160.
36. I Biroulet,C Neut,J Colombel (2008). Antimycobacterium therapy in Crohn's disease: the end of a long controversy?. Prac. Gastro, 1, 11-17.
37. William Chamberlin,Thomas Borody,Jordana Campbell (2011). Primary treatment of Crohn’s disease: combined antibiotics taking center stage. Expert Review of Clinical Immunology, 7(6), 751-760.
38. William Chamberlin,Thomas Borody,Jordana Campbell (2011). Primary treatment of Crohn’s disease: combined antibiotics taking center stage. Expert Review of Clinical Immunology, 7(6), 751-760.
